This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ken Mulvany Appointed Chairman Of The Cure Parkinson's Trust

About The Cure Parkinson's Trust

The Cure Parkinson's Trust is patient-led and involves people living with Parkinson's disease to help shape its research policy and priorities. The charity has one aim - to find a cure for Parkinson's. It funds innovative scientists with the aim of developing treatments to halt or reverse the condition. http://www.cureparkinsons.org.uk

Initiatives orchestrated by The Cure Parkinson's Trust to overcome the barriers to a cure include:

Linked Clinical Trials initiative

The Cure Parkinson's Trust relies on skilled scientists and the commitment of the pharmaceutical industry to ensure it fulfils its vision. Its Linked Clinical Trials initiative is designed to help mitigate risk for Industry, whilst opening up new avenues of investigation. This is an area where the new chairman has phenomenal expertise and experience. 

Sense-Park initiative

Working with a European consortium, CPT is developing new ways to measure Parkinson's, which in turn will have a significant impact on personalising Parkinson's treatment, as well as the measures and endpoints used in clinical trials. In the EU-funded Sense-Park project, technology allows us to provide continuous, objective and accurate measurement for the first time, using symptoms that have been determined as the most relevant by those living with the condition http://www.sense-park.eu

Parkinson's Movement

Created by people with Parkinson's for people with Parkinson's, Parkinson's Movement engages those living with the condition in better management and measurement of symptoms and in advancing treatments. http://www.parkinsonsmovement.com

M:Communications advises The Cure Parkinson's Trust on its communications. The Cure Parkinson's Trust is dedicated to finding, facilitating and funding work towards a cure for Parkinson's disease. 

For all media enquiries and for more information, please contact: Helen Matthews on +44(0)207-929-7656 / +44(0)7789842372,  helen@cureparkinsons.org.uk

Mary-Jane Elliott or Claire Dickinson M:Communications on +44(0)207-9202333

SOURCE The Cure Parkinson’s Trust

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs